Market Tracker

01/30 6:05pm ET

Actavis PLC (NYSE:ACT)

266.54
Data as of Jan 30
 -6.71 / -2.46%
Today’s Change
180.70
Today|||52-Week Range
285.09
+3.55%
Year-to-Date

Today’s Trading

Previous close273.25
Today’s open271.22
Day’s range266.18 - 273.03
Volume2,747,839
Average volume (3 months)3,076,531
Market cap$70.9B
Dividend yield--
Data as of 5:04pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)-793.42%
Earnings growth (this year)+44.03%
Earnings growth (next 5 years)+19.85%
Revenue growth (last year)+46.71%
P/E ratioNM
Price/Sales2.75
Price/Book4.87

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.50-1.10%
AGNAllergan-3.13-1.41%
LLYEli Lilly and Co-0.11-0.15%
VRXValeant Pharmaceutic...-1.54-0.95%
Data as of 5:03pm ET, 01/30/2015

Financials

Next reporting dateFebruary 18, 2015
EPS forecast (this quarter)$3.57
Annual revenue (last year)$8.7B
Annual profit (last year)-$750.4M
Net profit margin-8.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts